background image

BioInsights

Resources for healthcare investors

The Piper Sandler BioInsights research platform provides in-depth analyses across a diverse range of innovative and emerging therapeutic modalities, novel drug targets and disease states, through monthly thematic reports, expert events, catalyst calendars and more.

40

Thematic reports since 2019

161

Average page count per report*

27

Average companies profiled per report*

29+

Topics covered since 2019

Market-Driven, Actionable Insights

Piper Sandler’s thematic BioInsights reports dive deep into a diverse array of disease pathways, indications of interest and novel therapeutic modalities. The reports explore current and emerging competitive landscapes and provide detailed profiles of key public and private players in each space – reviewing relevant pipeline and marketed assets, available clinical data and upcoming catalysts of interest.

Emerging themes in biopharma

Artificial intelligence and machine learning, the evolution of generics and biosimilars.

Innovative therapeutic modalities and targets

Cell and gene therapies, engineered cytokines, RNA medicines, gene editing, drugging transcription factors, protein degradation, TGF-beta, and precision cardiovascular medicine.

Novel strategies to address disease indications

Chronic hepatitis B, women’s and men’s health, cystic fibrosis, medical dermatology, oncology, pain, epilepsy, gastrointestinal disorders, psychiatry and mood disorders, renal disorders, movement disorders, and sickle cell disease.

Catalyst Calendars

Our catalyst calendars include summaries of key biopharma events within the Piper Sandler coverage universe.

Key Opinion Leader Day Recaps

Key Opinion Leader day recaps provide detailed thoughts from panel discussions and key takeaways from industry leaders.

Conferences & Events

We bring together key industry executives and our own professionals to provide multiple perspectives, investigate critical trends, and identify the leaders in biopharma.

*Data for January 2021 through December 2022.

How can we help?